FMP
Principal Healthcare Innovators ETF
BTEC
NASDAQ
Inactive Equity
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
39.49 USD
0.4 (1.01%)
Historical Prices
From:
To:
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
CIK
0001572661
ISIN
US74255Y4098
CUSIP
74255Y409
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Aug 22, 2016
Sector Weightings
Country Weightings
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
BTEC Financial Summary
ISIN
US74255Y4098
Exchange
NASDAQ
Beta
1.03
Market Cap
16.19M
52-Week
25.66-41.1
Volume Avg.
1.78k
Price
39.49
Country
US
Management Assets
16.16M
Total Holdings
3
NAV
39.41
NAV Currency
USD
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BTEC News
ETF Trends
May 31, 2024
Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
Zacks Investment Research
Jul 25, 2023
Value ETF Investing to Shine as Sector Rotation Looks Likely...
As rising rates are in the cards, value stocks are likely to take a center stage in the near term.
Seeking Alpha
Jan 11, 2023
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
ETF Trends
Feb 3, 2022
Build Off Growth in Healthcare Innovation With BTEC
If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.
Zacks Investment Research
Oct 21, 2021
Can Biotech ETFs Gain From Positive Booster Update?
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.
Zacks Investment Research
Aug 20, 2021
Biotech ETFs to Benefit From Latest Booster Update
The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.
ETFcom
Aug 12, 2021
ETF Odds & Ends: 2 Active ESG Funds Debut
Two ESG-related ETFs launched this week, and both are heavy on the 'E.'
Zacks Investment Research
Aug 3, 2021
Delta Variant Surge Brings Biotech ETFs in Focus
The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.
